Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1

Stem Cells and Development

Volumn 20, Issue 8, 2011, Pages 1309-1318

  Stavroulaki, Emily ^a   Kastrinaki, Maria Christina ^a   Pontikoglou, Charalampos ^a   Eliopoulos, Dimitrios ^a   Damianaki, Athina ^a   Mavroudi, Irene ^a   Pyrovolaki, Katerina ^a   Katonis, Pavlos ^a   Papadaki, Helen A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CHRONIC IDIOPATHIC NEUTROPENIA; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NEUTROPENIA; OSTEOBLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; NEUTROPENIA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80051526117     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0425     Document Type: Article

References (36)

1. Papadaki HA, AG Eliopoulos, T Kosteas, C Gemetzi, A Damianaki, H Koutala, J Bux and GD Eliopoulos. (2003). Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 101:2591-2600. (Pubitemid 36857618)
2. Papadaki HA and C Pontikoglou. (2008). Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia. Expert Rev Hematol 1:217-229.
3. Papadaki HA, K Stamatopoulos, A Damianaki, C Gemetzi, A Anagnostopoulos, T Papadaki, AG Eliopoulos and GD Eliopoulos. (2005). Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol 128:863-876. (Pubitemid 40444882)
4. Papadaki HA, K Giouremou and GD Eliopoulos. (1999). Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells. Eur J Haematol 63:154-162. (Pubitemid 29406732)
5. Koumaki V, A Damianaki, M Ximeri, C Pontikoglou, F Axioti, M Spanoudakis, GD Eliopoulos and HA Papadaki. (2006). Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10. Br J Haematol 135:570-573. (Pubitemid 44583425)
6. Pontikoglou C, G Liapakis, K Pyrovolaki, M Papadakis, J Bux, GD Eliopoulos and HA Papadaki. (2006). Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia. (2006). Exp Hematol 34:1312-1322. (Pubitemid 44374831)
7. Psyllaki M, A Damianaki, C Gemetzi, Pyrovolaki K, Eliopoulos GD, and HA Papadaki H. (2006). Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow. Br J Haematol 134:624-631. (Pubitemid 44253606)
8. Bianco P, M Riminucci, S Gronthos and RG Robey. (2001). Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192. (Pubitemid 32524539)
9. Pittenger MF, AM Mackay, SC Beck, RK Jaswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
10. Pontikoglou C, B Delorme and P Charbord. (2008). Human bone marrow native mesenchymal stem cells. Regen Med 3:731-741.
11. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843. (Pubitemid 34534559)
12. Sotiropoulou PA and M Papamichail. (2002). Immune properties of mesenchymal stem cells. Methods Mol Biol 407: 225-243.
13. Deans RJ and AB Moseley. (2000). Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 28:875-884.
14. Klaus M, E Stavroulaki, MC Kastrinaki, P Fragioudaki, K Giannikou, M Psyllaki, C Pontikoglou, D Tsoukatou, C Mamalaki and HA Papadaki. (2010). Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev 19:1043-1054.
15. Flores-Figueroa E, JJ Montesinos, P Flores-Guzmán, G Gutiérrez-Espíndola, RM Arana-Trejo, S Castillo-Medina, A Pérez-Cabrera, E Hernández-Estévez, L Arriaga and HL Mayani. (2008). Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leuk Res 32: 1407-1416.
16. Xu Y, Y Takahashi, Y Wang, A Hama, N Nishio, H Muramatsu H, M Tanaka, N Yoshida, IB Villalobos, H Yagasaki and S Kojima. (2009). Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia. Exp Hematol 37:1393-1399.
17. Bacigalupo A, M Valle, M Podestà , A Pitto, E Zocchi, A De Flora, S Pozzi, S Luchetti, F Frassoni, MT Van Lint and G Piaggio. (2005). T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 33:819-827. (Pubitemid 40826596)
18. Xu Y, Y Takahashi, A Yoshimi, M Tanaka, H Yagasaki and S Kojima. (2009). Immunosuppressive activity of mesenchymal stem cells is not decreased in children with aplastic anemia. Int J Hematol 89:126-127.
19. Soenen-Cornu V, C Tourino, ML Bonnet, M Guillier, S Flamant, R Kotb, A Bernheim, JH Bourhis, C Preudhomme, P Fenaux and AG Turhan. (2005). Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support shortand long-term hematopoiesis in vitro. Oncogene 24:2441-2448. (Pubitemid 40593035)
20. Lopez-Villar O, JL Garcia, FM Sanchez-Guijo, C Robledo, EM Villaron, P Hernández-Campo, N Lopez-Holgado, M Diez-Campelo, MV Barbado, JA Perez-Simon, JM Hernández-Rivas, JF San-Miguel and MC del Cañizo. (2009). Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome. Leukemia 23:664-672.
21. Scholzen T and J Gerdes. (2010). The Ki-67 protein: From the known and the unknown. J Cell Physiol 182:311-322.
22. Philpott NJ, AJ Turner, J Scopes, M Westby, JC Marsh, EC Gordon-Smith, AG Dalgleish and FM Gibson. (1996). The use of 7-amino actinomycin D in identifying apoptosis: Simplicity of use and broad spectrum of application compared with other techniques. Blood 87:2244-2251. (Pubitemid 26086863)
23. Delorme B and P Charbord. (2007). Culture and characterisation of human bone marrow mesenchymal stem cells. In: Methods in Molecular Medicine, 2nd edition: Tissue Engineering. Hauser H, M Fussenegger, eds. Humana Press Inc., Totowa, NJ, pp 67-82.
24. Gronthos S, SE Graves and PJ Simmons. (1998). Isolation, purification and in vitro manipulation of human bone marrow stromal precursor cells. In: Marrow stromal cell culture. Beresford JN, ME Owen, eds. Cambridge University Press, Cambridge, pp 26-42.
25. Kastrinaki MC, I Andreakou, P Charbord and HA Papadaki. (2008). Isolation of human bone marrow mesenchymal stem cells using different membrane markers: Comparison of colony/cloning efficiency, differentiation potential, and molecular profile. Tissue Eng Part C Methods 14:333-339.
26. In't Anker PS, WA Noort, SA Scherjon, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe. (2003). Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852. (Pubitemid 37128084)
27. Kastrinaki MC, P Sidiropoulos, S Roche, J Ringe, S Lehmann, H Kritikos, VM Vlahava, B Delorme, GD Eliopoulos, C Jorgensen, P Charbord, T Hä upl, DT Boumpas and HA Papadaki. (2008). Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 67:741-749. (Pubitemid 351829372)
28. Rizzo S, J Scopes, MO Elebute, HA Papadaki, EC Gordon-Smith and FM Gibson. (2002). Stem cell defect in aplastic anemia: Reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow. Hematol J 3:230-236. (Pubitemid 35331382)
29. Kastrinaki MC, C Pontikoglou, M Klaus, E Stavroulaki, K Pavlaki and HA Papadaki. (2010). Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes. Curr Stem Cell Res PMID: 20528751 [Epub ahead of print].
30. Klyushnenkova E, JD Mosca, V Zernetkina, MK Majumdar, KJ Beggs, DW Simonetti, RJ Deans and KR McIntosh. (2005). T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci 12:47-57. (Pubitemid 40576763)
31. Shu XO, YT Gao, Q Cai, L Pierce, H Cai, ZX Ruan, G Yang, F Jin and W Zheng. (2004). Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: A report from the Shanghai Breast Cancer Study. Cancer Res 64:836-839. (Pubitemid 38176881)
32. Eliopoulos DG, I Mavroudi, C Pontikoglou, M Ximeri, E Stavroulaki, K Pyrovolaki, M Velegraki, M Spanoudakis, G Goulielmos and HA Papadaki. (2009). The-509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia. Eur J Haematol 83:535-540.
33. Pyrovolaki K, I Mavroudi, N Papadantonakis, M Velegraki, M Ximeri, C Kalpadakis, G Gvazava, M Klaus, GD Eliopoulos and HA Papadaki. (2007). Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia. Eur J Haematol 79:531-538. (Pubitemid 350126670)
34. Fortunel NO, JA Hatzfeld, MN Monier and A Hatzfeld. (2003). Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol Res 13:445-453.
35. Jian H, X Shen, I Liu, M Semenov, X He and XF Wang. (2006). Smad3-dependent nuclear translocation of betacatenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20:666-674.
36. Mishra L, R Derynck and B Mishra. (2005). Transforming growth factor-beta signaling in stem cells and cancer. Science 310:68-71. (Pubitemid 41434534)